Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th

Company Overview - Recursion (NASDAQ:RXRX) is a clinical stage TechBio company focused on decoding biology to enhance drug discovery processes [3] - The company operates a platform known as Recursion OS, which generates extensive proprietary biological and chemical datasets, utilizing advanced machine-learning algorithms to identify relationships across biology and chemistry [3] - Recursion conducts millions of wet lab experiments weekly and operates one of the most powerful supercomputers globally, integrating technology with biology and chemistry to innovate in medicine [3] Upcoming Financial Updates - Recursion will provide business updates and report its fourth quarter and full year 2024 financial results on February 28, 2025, before the market opens [1] - An earnings call will be held on the same day at 8:30 am ET, with a live stream available on various platforms including X (formerly Twitter), LinkedIn, and YouTube [2] Company Locations - The company is headquartered in Salt Lake City and is a founding member of BioHive, a collective for the Utah life sciences industry [4] - Recursion has additional offices in Toronto, Montréal, New York, London, Oxford area, and the San Francisco Bay area [4]